Serving To Educate Primary Care Clinicians On Respiratory Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Metabolic Diseases Header 4
News: Articles from our Partners at Consultant 360 April 2018

New Respiratory Disease Articles from our Partners at Consultant 360

Varenicline Effective for Smoking Cessation After Heart Attack

Individuals who continue smoking following acute coronary syndrome have an increased risk of reinfarction and mortality. In a new study, researchers aimed to determine the effectiveness of varenicline for increasing smoking abstinence in ACS patients.

Asthma Exacerbation Risk Factors Differ by Severity

Following a recent study of 22,130 adult patients with mild to moderate asthma or severe asthma, researchers have pinpointed the risk factors for exacerbation in both patient populations.

Tuberculosis Raises the Risk for a First Heart Attack

It is well-known that tuberculosis is associated with an increased risk for cardiovascular disease. However, the researchers investigated whether latent tuberculosis infection is linked with acute myocardial infarction risk.

New Asthma Management Tool Greatly Improves Control

In a recent study, researchers investigated the impact of implementing the Asthma Activities, Persistent, triGGers, Asthma Medications, Response to therapy (APGAR) tools for the treatment of children and adults with persistent asthma.

Smoking Increases Risk of Hearing Loss

Little evidence is available of the association between smoking and hearing loss. In a recent study, examined this relationship and how it was affected by smoking intensity and cessation.